Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home hepatitis c tests could reach thousands in pakistan

NCT ID NCT04971538

Diagnosis Sponsor: Foundation for Innovative New Diagnostics, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers in Karachi, Pakistan, are studying whether delivering hepatitis C self-tests to people's homes increases how many get tested. The trial enrolls about 2,000 adults who live in two areas of the Malir district and have not recently been tested. Half receive a self-test kit at home, and the other half receive standard care. The study compares testing rates between the two groups and tracks how many people who test positive learn their status.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
OraQuick HCV self-test, a rapid oral fluid test for hepatitis C antibodies
What this could lead to
If home self-testing works, it could become a model for reaching people with hepatitis C who avoid clinics, helping countries move closer to eliminating the infection.
What could go wrong
Self-testing may not appeal to everyone, and some people who test positive may not seek follow-up care. The study measures testing rates, not whether treatment cures the infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,000 people

The number who actually took part.

Started

Nov 2021

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * Residing in UC 9 or 10 * Eligible for inclusion in the larger AKU micro-elimination study Exclusion Criteria: * Known to be HCV antibody positive * Tested for HCV within the last 6 months * At home during the visit by AKU staff for this study and available to be tested by study staff with an onsite RDT

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diagnostic self evaluation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diagnostic self evaluation Hepatitis C

Contacts and locations

Locations

  • Aga Khan University

    Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.